- Home
- BIDU vs KTTA Comparison
BIDU vs KTTA Comparison
Compare BIDU & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIDU | KTTA |
|---|---|---|
| Founded | 2000 | 2020 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9B | 5.3M |
| IPO Year | 2005 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BIDU | KTTA |
|---|---|---|
| Price | $123.33 | $1.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $144.23 | $3.00 |
| AVG Volume (30 Days) | 2.4M | ★ 17.9M |
| Earning Date | 11-18-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.25 | N/A |
| Revenue | ★ $18,325,514,127.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.78 | N/A |
| P/E Ratio | $38.12 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $74.71 | $0.28 |
| 52 Week High | $149.51 | $3.85 |
Technical Indicators
Market Signals| Indicator | BIDU | KTTA |
|---|---|---|
| Relative Strength Index (RSI) | 52.12 | 59.44 |
| Support Level | $121.80 | $1.02 |
| Resistance Level | $125.37 | $1.21 |
| Average True Range (ATR) | 2.91 | 0.09 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 40.16 | 50.22 |
Price Performance
Historical ComparisonAbout BIDU Baidu Inc. ADS
Baidu is the largest internet search engine in China with over 50% share of the search engine market in 2024 per web analytics firm, Statcounter. The firm generated 70% of core revenue from online marketing services from its search engine in 2024. Outside its search engine, Baidu is a technology-driven company and its other major growth initiatives are artificial intelligence cloud, video streaming services, voice recognition technology, and autonomous driving.
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).